Ming Yin Selected Research

Rheumatoid Arthritis

5/2010	Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trial.
9/2007	Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming Yin Research Topics

Disease

36	Neoplasms (Cancer) 04/2021 - 01/2004
12	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2008
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013 - 01/2009
7	Neoplasm Metastasis (Metastasis) 12/2022 - 05/2004
7	Inflammation (Inflammations) 05/2022 - 12/2001
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 02/2013
6	Ischemia 09/2019 - 12/2001
5	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 06/2009
5	Reperfusion Injury 01/2019 - 12/2001
5	Radiation Pneumonitis 01/2013 - 01/2011
4	Carcinogenesis 02/2016 - 08/2010
4	Lung Neoplasms (Lung Cancer) 10/2014 - 01/2009
4	Melanoma (Melanoma, Malignant) 08/2014 - 05/2004
4	Asthma (Bronchial Asthma) 12/2005 - 02/2003
3	Infections 02/2021 - 09/2004
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2016
3	Pain (Aches) 12/2020 - 01/2006
3	Fever (Fevers) 08/2020 - 01/2006
3	Parkinson Disease (Parkinson's Disease) 10/2016 - 07/2014
3	Osteosarcoma (Osteogenic Sarcoma) 06/2016 - 11/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2014 - 01/2009
3	Cognitive Dysfunction 04/2014 - 08/2012
3	Hypoxia (Hypoxemia) 06/2012 - 03/2002
3	Adenocarcinoma 01/2012 - 10/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 03/2022
2	Hemorrhage 01/2021 - 03/2003
2	Hepatitis 05/2020 - 09/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 10/2014
2	Acute Kidney Injury (Acute Renal Failure) 09/2019 - 12/2001
2	Carcinoma (Carcinomatosis) 02/2019 - 01/2019
2	Septic Shock (Toxic Shock Syndrome) 01/2019 - 01/2012
2	Leukemia 03/2018 - 01/2004
2	Wounds and Injuries (Trauma) 09/2016 - 03/2002
2	Osteoporosis 11/2015 - 01/2015
2	Neutropenia 10/2014 - 03/2014
2	Sarcoma (Soft Tissue Sarcoma) 10/2014 - 10/2014
2	Exanthema (Rash) 08/2014 - 03/2014
2	Genomic Instability 01/2012 - 01/2011
2	Rheumatoid Arthritis 05/2010 - 09/2007
2	Ulcer 04/2007 - 03/2003
2	Fibrosis (Cirrhosis) 03/2002 - 12/2001

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 12/2022 - 01/2013
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2001
5	EnzymesIBA 05/2022 - 05/2004
5	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 05/2018
5	PlatinumIBA 01/2020 - 06/2011
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2009
5	Cisplatin (Platino)FDA LinkGeneric 03/2018 - 01/2012
4	Immune Checkpoint InhibitorsIBA 01/2022 - 05/2020
4	Oxygen (Dioxygen)IBA 01/2019 - 02/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 09/2004
4	Insulin (Novolin)FDA Link 08/2011 - 01/2009
3	enzalutamideIBA 12/2022 - 10/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 12/2001
3	NivolumabIBA 01/2022 - 05/2020
3	IpilimumabIBA 01/2022 - 05/2020
3	CytokinesIBA 09/2019 - 01/2004
3	AntioxidantsIBA 09/2019 - 01/2015
3	Neuroprotective AgentsIBA 09/2016 - 07/2014
3	Biological ProductsIBA 02/2016 - 01/2009
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2014 - 09/2007
3	Amyloid (Amyloid Fibrils)IBA 12/2013 - 01/2008
3	Codon (Codons)IBA 01/2012 - 10/2007
3	AllergensIBA 07/2004 - 02/2003
2	abirateroneIBA 12/2022 - 12/2020
2	ImmunosorbentsIBA 05/2022 - 05/2004
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2021
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 01/2009
2	Peptides (Polypeptides)IBA 02/2021 - 04/2014
2	Chimeric Antigen ReceptorsIBA 02/2019 - 03/2018
2	Propofol (Diprivan)FDA LinkGeneric 01/2019 - 01/2019
2	Caspase 3 (Caspase-3)IBA 06/2016 - 11/2013
2	IronIBA 11/2015 - 01/2015
2	Estrogens (Estrogen)FDA Link 11/2015 - 05/2010
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2015 - 01/2004
2	Fluorouracil (Carac)FDA LinkGeneric 10/2014 - 10/2014
2	VemurafenibIBA 08/2014 - 03/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 12/2001
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012 - 08/2010
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2012 - 01/2004
2	Caspase 8 (Caspase-8)IBA 01/2012 - 05/2010
2	Monoclonal AntibodiesIBA 11/2011 - 08/2008
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 10/2010 - 01/2008
2	Rituximab (Mabthera)FDA Link 05/2010 - 09/2007
2	Nasal SpraysIBA 02/2008 - 01/2006
2	EndotoxinsIBA 12/2005 - 03/2003
2	Interleukin-1 (Interleukin 1)IBA 06/2004 - 12/2001
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 03/2003 - 03/2002
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2002 - 12/2001
1	Testosterone (Sustanon)FDA Link 12/2022

Therapy/Procedure

18	Therapeutics 01/2022 - 01/2009
7	Drug Therapy (Chemotherapy) 12/2022 - 03/2011
5	Radiotherapy 01/2020 - 01/2011
4	Immunotherapy 01/2021 - 03/2018
3	Neoadjuvant Therapy 01/2021 - 01/2016
2	Resuscitation 01/2019 - 01/2014
2	Intravenous Injections 03/2018 - 12/2001
2	Mastectomy (Mammectomy) 01/2017 - 11/2016
2	Transplantation 01/2015 - 03/2002
2	Retreatment 05/2010 - 09/2007